A compound and method for treating a patient with multiple sclerosis symptoms is disclosed. The compound includes from approximately 1 milligrams to approximately 4 milligrams of vitamin B12, from approximately 150 milligrams to approximately 300 milligrams of biotin, from approximately 1 milligram to approximately 4 milligrams of folate, from approximately 2000 international units to approximately 10,000 international units of vitamin D3, from approximately 100 milligrams to approximately 1000 milligrams of vitamin C, from approximately 300 milligrams to approximately 1200 milligrams of n-acetylcysteine, from approximately 10 milligrams to approximately 50 milligrams of green coffee bean extract, and from approximately 100 milligrams to approximately 1000 milligrams of turmeric concentrate. The method for treating a patient with multiple sclerosis symptoms includes the steps of providing the compound, apportioning the compound into a set of dosages of the compound, and administering the set of dosages of the compound based on a set of times.
